Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Allocation / Balanced · Gmo

GMO Benchmark-Free Allocation Fund Class R6 (GBMSX)

Ticker GBMSX · Since 2020-05-01 · · Holdings as of May 31, 2026

Expense ratio
1.35%$135/yr per $10k
5-yr return
+7.9%annualized
1-yr return
+22.9%as of Dec 2025
Net assets
$2.6Ball share classes
Holdings
6

Bottom line

Is GBMSX a good fund? The bottom line

GBMSX is the Class R6 share class of GMO Benchmark-Free Allocation Fund, a managed allocation / balanced mutual fund from Gmo.

Its expense ratio is 1.35% — about $135 a year on every $10,000 invested, more expensive than 81% of allocation / balanced funds we track.

It returned +22.9% over one year, +7.9% a year over five years (as of Dec 31, 2025, per its prospectus).

With $2.6 billion in net assets and 6 holdings, its largest position is GMO Implementation Fund (83.7%) and the top 10 make up 100.1% of the portfolio.

What stands out

  • 5-year return beat 81% of category peers

What to watch

  • Expensive for its category (1.35%)
  • Concentrated: top 10 holdings are 100.1% of assets

Updated Nov 19, 2026

What GBMSX invests in

Positive total return.

The Fund seeks annualized returns of 5% (net of fees) above the Consumer Price Index and expects annualized volatility (standard deviation) of 5-10%, each over a complete market cycle. GMO does not manage the Fund to, or control the Funds risk relative to, any securities index or securities benchmark. The Fund is a fund of funds and invests primarily in Implementation Fund, other series of GMO Trust whether now existing or created in the future, including the Fixed Income Funds and the Alternative Funds, and in GMO-managed exchange-traded funds (collectively, the underlying GMO Funds) (see Additional Information About the Funds Investment Strategies, Risks, and Expenses Asset Allocation Funds). GMO seeks to achieve the Funds investment objective by investing the Funds assets in asset classes GMO believes offer the most attractive risk-adjusted returns. GMO uses its quantitative…

From the fund's prospectus (filed Oct 20, 2026).

GBMSX performance

Average annual total returns
1 yr5 yr10 yr
GBMSX+22.9%+7.9%—
Allocation / Balanced median+11.0%+5.7%+6.7%

Source: Fund prospectus, as of Dec 31, 2025

Full GBMSX performance history →

What GBMSX costs

On a $10,000 investment, GBMSX's 1.35% expense ratio costs about $135 a year. The prospectus estimates $1,778 in total costs over 10 years (assuming 5% annual returns). The median allocation / balanced fund charges 0.91%.

See the full GBMSX fee table →

GBMSX top 10 holdings

#Holding% of fund
1GMO Implementation Fund83.70%
2GMO Alternative Allocation Fund12.27%
3GMO Opportunistic Income Fund1.88%
4GMO Climate Change Fund1.11%
5GMO High Yield Fund0.99%
6State Street Global Advisors0.13%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 100.1% of the fund. See all top 25 holdings and asset mix →

Alternatives to GBMSX

More funds like GBMSX →

GBMSX FAQ

What is the expense ratio of GBMSX?
GBMSX's expense ratio is 1.35%, which works out to about $135 a year for every $10,000 invested. The prospectus estimates total costs of $1,778 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is GBMSX a good investment?
It depends on your goals, but the data points to: 5-year return beat 81% of category peers; expensive for its category (1.35%); concentrated: top 10 holdings are 100.1% of assets. This is general information, not personalized advice.
What does GBMSX hold?
GBMSX's largest holdings are GMO Implementation Fund (83.7%), GMO Alternative Allocation Fund (12.3%), GMO Opportunistic Income Fund (1.9%), GMO Climate Change Fund (1.1%), GMO High Yield Fund (1.0%). It holds 6 positions in total as of May 31, 2026 (SEC Form N-PORT).
What is GBMSX's 5-year return?
GBMSX returned +7.9% a year over the five years ending Dec 31, 2025. Past performance does not guarantee future results.
Who manages GBMSX?
GBMSX is offered by Gmo through Gmo Trust.